These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 12133516

  • 1. [Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].
    Shi Y, Han X, He X, Yang J, Liu P.
    Zhonghua Yi Xue Za Zhi; 2002 Apr 10; 82(7):462-6. PubMed ID: 12133516
    [Abstract] [Full Text] [Related]

  • 2. [Mobilization of autologous peripheral blood stem cells with etoposide and recombinant human granulocyte colony stimulating factor in malignant tumor patients].
    Shi YK, He XH, Han XH, Yang JL, Liu P, Zhang CG, Ai B.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 10; 26(6):360-3. PubMed ID: 15312348
    [Abstract] [Full Text] [Related]

  • 3. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK, He XH, Han XH, Liu P, Yang JL, Zhou SY, Zhou AP, Zhang CG, Ai B.
    Ai Zheng; 2003 Dec 10; 22(12):1311-6. PubMed ID: 14693058
    [Abstract] [Full Text] [Related]

  • 4. [Mobilization of autologous peripheral blood stem cells by combined chemotherapy and rhG-CSF].
    Shi H, Gu X, Zhu L.
    Zhonghua Zhong Liu Za Zhi; 2001 Mar 10; 23(2):159-61. PubMed ID: 11783025
    [Abstract] [Full Text] [Related]

  • 5. [Mobilization of autologous peripheral blood stem cells by cyclophosphamide and recombinant human granulocyte colony-stimulating factor(rhG-CSF)].
    Shi Y, Zhou S, Han X.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug 10; 19(8):425-7. PubMed ID: 11189511
    [Abstract] [Full Text] [Related]

  • 6. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Cui X, Shao Y, Ren B, Tong Z, Ren X, Li L, Zhang Z, Zhang N, Dai R, Hao X.
    Zhonghua Xue Ye Xue Za Zhi; 2000 May 10; 21(5):247-9. PubMed ID: 11876989
    [Abstract] [Full Text] [Related]

  • 7. [Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies].
    Qiu HY, Wu DP, Sun AN, Chang WR, Jin ZM, Miao M, Tang XW, Shen YM, Fu ZZ.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug 10; 25(8):462-5. PubMed ID: 15555260
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct 10; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 9. [A clinical study of rhG-CSF in accelerating hematological recovery following autologous hematopoietic stem cells transplantation].
    Yang JL, Shi YK, He XH, Zhou SY, Zhou AP, Han XH, Liu P, Zhang CG, Ai B.
    Ai Zheng; 2003 Aug 10; 22(8):785-9. PubMed ID: 12917020
    [Abstract] [Full Text] [Related]

  • 10. [Clinical study on single-dose rhG-CSF combined with chemotherapy in autologous peripheral blood stem cell transplantation].
    Tian H, Zhou SY.
    Ai Zheng; 2002 Aug 10; 21(8):896-9. PubMed ID: 12478902
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 10; 28(3):339-44. PubMed ID: 16900629
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffman R, Sheay W, Cody R, Philipp C, Resta D, George M.
    Exp Hematol; 1996 Jun 10; 24(7):839-47. PubMed ID: 8647235
    [Abstract] [Full Text] [Related]

  • 13. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 10; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 14. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
    Gómez-Espuch J, Moraleda JM, Ortuño F, Lozano ML, Ayala F, Vallejo C, de Arriba F, Vicente V.
    Bone Marrow Transplant; 2000 Feb 10; 25(3):231-5. PubMed ID: 10673692
    [Abstract] [Full Text] [Related]

  • 15. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E, Castagna L, Sarina B, Mazza R, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Anastasia A, Demarco M, Santoro A.
    Eur J Haematol; 2007 Feb 10; 78(2):111-6. PubMed ID: 17313558
    [Abstract] [Full Text] [Related]

  • 16. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY, Xu B, Sun J, Yang Y, Niu JN.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep 10; 24(9):1051-2. PubMed ID: 15447861
    [Abstract] [Full Text] [Related]

  • 17. Mobilization of peripheral blood progenitor cells by high-dose Ara C, VP-16 and recombinant human granulocyte colony-stimulating factor: factors affecting progenitor cell yields.
    Shimazaki C, Yamagata N, Tatsumi T, Hirata T, Oku N, Ashihara E, Goto H, Inaba T, Fujita N, Haruyama H.
    Bone Marrow Transplant; 1995 May 10; 15(5):763-7. PubMed ID: 7545490
    [Abstract] [Full Text] [Related]

  • 18. Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.
    Shimazaki C, Oku N, Ashihara E, Okawa K, Goto H, Inaba T, Ito K, Fujita N, Tsuji H, Murakami S.
    Bone Marrow Transplant; 1992 Oct 10; 10(4):341-6. PubMed ID: 1384902
    [Abstract] [Full Text] [Related]

  • 19. [High-dose chemotherapy supported by peripheral blood stem cells to treat intermediate--and high-grade non-Hodgkin's lymphomas].
    Ji Y, Ji S, Ju X.
    Zhonghua Zhong Liu Za Zhi; 1996 Nov 10; 18(6):471-5. PubMed ID: 9387307
    [Abstract] [Full Text] [Related]

  • 20. Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvest.
    Juweid ME, Blumenthal RD, Lew W, Hajjar G, Rubin AD, Goldenberg DM.
    Clin Cancer Res; 1999 Oct 10; 5(10 Suppl):3337s-3342s. PubMed ID: 10541383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.